The cancer stem Cell theory: Is it correct?

Molecules and Cells

Volumn 26, Issue 5, 2008, Pages 514-516

  Yoo, Min Hyuk ^a   Hatfield, Dolph L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer cells; Cancer stem cells; Lung cancer cells; Single cell originated cells; Tumor growth

Indexed keywords

CELL SURFACE MARKER; STEM CELL ANTIGEN 1;

ALLOTRANSPLANTATION; ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; C57BL 6 MOUSE; CANCER CELL CULTURE; CANCER STEM CELL; CELL CULTURE; CELL GROWTH; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; EXPERIMENTAL TRANSPLANTATION; LUNG CANCER; MOUSE; NONHUMAN; XENOTRANSPLANTATION;

ANIMALS; CELL LINE; HUMANS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; REPRODUCIBILITY OF RESULTS;

MUS;

EID: 58049124353     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.
2. Bertram, J.S., and Janik, P. (1980). Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett. 11, 63-73.
3. Bonnet, D., and Dick, J.E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
4. Clarke, M.F., Dick, J.E., Dirks, P.B., Eaves, C.J., Jamieson, C.H., Jones, D.L., Visvader, J., Weissman, I.L., and Wahl, G.M. (2006). Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339-9344.
5. Dick, J.E. (2003). Breast cancer stem cells revealed. Proc. Natl. Acad. Sci. USA 100, 3547-3549.
6. Grichnik, J.M. (2006). Genomic instability and tumor stem cells. J. Invest. Dermatol. 126, 1214-1216.
7. Hope, K.J., Jin, L., and Dick, J.E. (2004). Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5, 738-743.
8. Huff, C.A., Matsui, W.H., Douglas Smith, G., and Jones, R.J. (2006). Strategies to eliminate cancer stem cells: clinical implications. Eur. J. Cancer. 42, 1293-1297.
9. Jordan, C.T. (2004). Cancer stem cell biology: from leukemia to solid tumors. Curr. Opin. Cell Biol. 16, 708-712.
10. Kelly, P.N., Dakic, A., Adams, J.M., Nutt, S.L., and Strasser, A. (2007). Tumor growth need not be driven by rare cancer stem cells. Science 317, 337.
11. Kennedy, J.A., Barabé, F., Poeppl, A.G., Wang, J.C., and Dick, J.E. (2007). Comment on "Tumor growth need not be driven by rare cancer stem cells". Science 318, 1722.
12. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N.M., Pastorino, S., Purow, B.W., Christopher, N., Zhang, W., et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403.
13. Massard, C., Deutsch, E., and Soria, J.C. (2006). Tumour stem cell-targeted treatment: elimination or differentiation. Ann. Oncol. 17, 1620-1624.
14. O'Brien, C.A., Pollett, A., Gallinger, S., and Dick, J.E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106-110.
15. Polyak, K. (2007). Breast cancer: origins and evolution. J. Clin. Invest. 117, 3155-3163.
16. Rockwell, S.C., Kallman, R F., and Fajardo, L.F. (1972). Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 49, 735-749.
17. Singh, S.K., Clarke, I.D., Hide, T., and Dirks, P.B. (2004a). Cancer stem cells in nervous system tumors. Oncogene 23, 7267-7273.
18. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., and Dirks, P.B. (2004b). Identification of human brain tumour initiating cells. Nature 432, 396-401.
19. Stingl, J., and Caldas, C. (2007). Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer 7, 791-799.
20. Wang, S., Garcia, A.J., Wu, M., Lawson, D.A., Witte, O.N., and Wu, H. (2006). Pten deletion leads to the expansion of a prostatic stem/ progenitor cell subpopulation and tumor initiation. Proc. Natl. Acad. Sci. USA 103, 1480-1485.
21. Yang, X.F. (2007). Immunology of stem cells and cancer stem cells. Cell Mol. Immunol. 4, 161-171.
22. Yoo, M.H., Xu, X.M., Carlson, B.A., Gladyshev, V.N., and Hatfield, D.L. (2006). Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J. Biol. Chem. 281, 13005-13008.